Expression of Modulates the Progression of Mutated Thyroid Cancer Cells

Expression of Modulates the Progression of Mutated Thyroid Cancer Cells

BackgroundWe previously reported the frequent neurofibromatosis 2 (NF2) gene mutations in anaplastic thyroid cancers in association with the BRAFV600E mutation. We aimed to investigate the role of NF2 in thyroid cancer with BRAF mutation.MethodsTo identify the function of NF2 in thyroid cancers, we...

Full description

Bibliographic Details
Main Authors:	Mi-Hyeon You, Min Ji Jeon, Tae Yong Kim, Won Bae Kim, Young Kee Shong, Won Gu Kim
Format:	Article
Language:	English
Published:	Academya Publishing Co. 2019-06-01
Series:	Endocrinology and Metabolism
Subjects:	Neurofibromatosis 2 BRAF, mutation Thyroid neoplasms Genes, tumor suppressor
Online Access:	https://e-enm.org/Synapse/Data/PDFData/2008ENM/enm-34-203.pdf

Similar Items

Comparison of Immunohistochemistry and Direct Sanger Sequencing for Detection of the Mutation in Thyroid Neoplasm
by: Hye-Seon Oh, et al.
Published: (2018-01-01)

Clinical implications of the BRAF mutation in papillary thyroid carcinoma and chronic lymphocytic thyroiditis
by: Woon Won Kim, et al.
Published: (2018-01-01)

The Frequency and Clinical Implications of the BRAF Mutation in Papillary Thyroid Cancer Patients in Korea Over the Past Two Decades
by: A Ram Hong, et al.
Published: (2014-12-01)

Prevalence of BRAF Mutation in Papillary Thyroid Cancer
by: Shatha Dmour, et al.
Published: (2016-12-01)

Low Prevalence of Somatic Promoter Mutations in Classic Papillary Thyroid Carcinoma
by: Min Ji Jeon, et al.
Published: (2016-03-01)

Current Status and Future Perspectives in Differentiated Thyroid Cancer
by: Tae Yong Kim, et al.
Published: (2014-09-01)

Unmet Clinical Needs in the Treatment of Patients with Thyroid Cancer
by: Won Bae Kim, et al.
Published: (2020-03-01)

Active Surveillance as an Effective Management Option for Low-Risk Papillary Thyroid Microcarcinoma
by: Min Ji Jeon, et al.
Published: (2021-08-01)

Telomerase reverse transcriptase promoter mutation and its clinical implication in thyroid cancer
by: Jae Hoon Chung
Published: (2018-03-01)

The Impact of BRAF Mutation on the Recurrence of Papillary Thyroid Carcinoma: A Meta-Analysis
by: Xin Li, et al.
Published: (2020-07-01)

Association between BRAF (V600E) mutation and clinicopathological features of papillary thyroid carcinoma: a Brazilian single-centre case series
by: Danielle Pessôa-Pereira, et al.
Published: (2019-03-01)

BRAF mutation in papillary thyroid microcarcinoma – additional marker of risk stratification
by: Dmitriy Yuriyevich Semyonov, et al.
Published: (2014-11-01)

Clinical Outcomes of Differentiated Thyroid Cancer Patients with Local Recurrence or Distant Metastasis Detected in Old Age
by: Ji Min Han, et al.
Published: (2018-11-01)

Standardized Thyroid Cancer Mortality in Korea between 1985 and 2010
by: Yun Mi Choi, et al.
Published: (2014-12-01)

BRAF Inhibitors in Thyroid Cancer: Clinical Impact, Mechanisms of Resistance and Future Perspectives
by: Fabiana Crispo, et al.
Published: (2019-09-01)

Predicting Extrathyroidal Extension in Patients With Papillary Thyroid Microcarcinoma According to a BRAF Mutation
by: Doh Young Lee, et al.
Published: (2017-06-01)

Solitary Skin Metastasis of Papillary Thyroid Carcinoma
by: Hyemi Kwon, et al.
Published: (2014-12-01)

Clinical Outcomes of N1b Papillary Thyroid Cancer Patients Treated with Two Different Doses of Radioiodine Ablation Therapy
by: Meihua Jin, et al.
Published: (2020-09-01)

Higher Integrin Alpha 3 Beta1 Expression in Papillary Thyroid Cancer Is Associated with Worst Outcome
by: Lorenza Mautone, et al.
Published: (2021-06-01)

BRAF mutation in cytologically indeterminate thyroid nodules: after reclassification of a variant thyroid carcinoma
by: Pongsapich W, et al.
Published: (2019-02-01)

Evaluation of the expression levels of BRAF V600E mRNA in primary tumors of thyroid cancer using an ultrasensitive mutation assay
by: Tien Viet Tran, et al.
Published: (2020-05-01)

THE ROLE OF BRAF MUTATION STATUS IN SURGICAL TREATMENT OF WELL-DIFFERENTIATED THYROID CANCER
by: A. P. Polyakov, et al.
Published: (2017-04-01)

A case report of simultaneous medullary and papillary carcinoma of thyroid
by: Ziaolhagh Reza, et al.
Published: (2021-04-01)

Modification of the Tumor-Node-Metastasis Staging System for Differentiated Thyroid Carcinoma by Considering Extra-Thyroidal Extension and Lateral Cervical Lymph Node Metastasis
by: Mijin Kim, et al.
Published: (2020-03-01)

Combined analysis of BRAF-gene mutation and galectin-3 expression in preoperative diagnostics of thyroid cancer
Published: (2011-06-01)

Co-existence of BRAFV600E and TERT promoter mutations in papillary thyroid carcinoma is associated with tumor aggressiveness, but not with lymph node metastasis
by: Ren HY, et al.
Published: (2018-05-01)

Active Surveillance of Papillary Thyroid Microcarcinoma: A Mini-Review from Korea
by: Tae Yong Kim, et al.
Published: (2017-12-01)

BRAF gene mutations in synchronous papillary thyroid carcinoma and Langerhans cell histiocytosis co-existing in the thyroid gland: a case report and literature review
by: Mohammad A. Al Hamad, et al.
Published: (2019-02-01)

Somatic mutation testing: the role in differential diagnosis of thyroid neoplasms
by: Vera A. Kachko, et al.
Published: (2019-08-01)

Lack of Associations between Body Mass Index and Clinical Outcomes in Patients with Papillary Thyroid Carcinoma
by: Hyemi Kwon, et al.
Published: (2015-09-01)

Differentiated Thyroid Papillary Carcinoma with Cerebellar Metastasis: A Case Report
by: Elif Turan, et al.
Published: (2017-03-01)

Molecular Diagnosis Using Residual Liquid-Based Cytology Materials for Patients with Nondiagnostic or Indeterminate Thyroid Nodules
by: Hyemi Kwon, et al.
Published: (2016-12-01)

Clinical Outcomes after Early and Delayed Radioiodine Remnant Ablation in Patients with Low-Risk Papillary Thyroid Carcinoma: Propensity Score Matching Analysis
by: Jonghwa Ahn, et al.
Published: (2020-12-01)

Frequency and Significance of Ras, Tert Promoter, and Braf Mutations in Cytologically Indeterminate Thyroid Nodules: A Monocentric Case Series at a Tertiary-Level Endocrinology Unit
by: Simona Censi, et al.
Published: (2017-10-01)

Relevance and clinicopathologic relationship of BRAF V600E, TERT and NRAS mutations for papillary thyroid carcinoma patients in Northwest China
by: Meiling Huang, et al.
Published: (2019-07-01)

Mutation of the BRAF Genes in Non-small Cell Lung Cancer
by: Zhimin HUANG, et al.
Published: (2012-03-01)

A Closer Look at Papillary Thyroid Carcinoma
by: Won Bae Kim
Published: (2015-03-01)

Utility of BRAF VE1 Immunohistochemistry as a Screening Tool for Colorectal Cancer Harboring V600E Mutation
by: Jeong-Hwa Kwon, et al.
Published: (2018-05-01)

Coexistence of TERT Promoter Mutations and the BRAF V600E Alteration and Its Impact on Histopathological Features of Papillary Thyroid Carcinoma in a Selected Series of Polish Patients
by: Dagmara Rusinek, et al.
Published: (2018-09-01)

<i>TERT</i> Promoter Mutations and the 8th Edition TNM Classification in Predicting the Survival of Thyroid Cancer Patients
by: Jun Park, et al.
Published: (2021-02-01)

Cannot write session to /tmp/vufind_sessions/sess_a6ojvq0b6si1sgd6tbislkvjh0